{
    "RADCURE-1483": {
        "question": "Age: 75.8, Sex: Female, ECOG PS: ECOG 0, Smoking PY: 30, Smoking Status: Ex-smoker, Ds Site: Oropharynx, Subsite: Base of Tongue, T: T3, N: N2c, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: positive, Tx Modality: RT alone, Chemo? : none, Dose: 60.0, Fx: 40, Local: none, Regional: none, Distant: none, 2nd Ca: Y, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-positive cases. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "The provided CT scan image shows a head and neck region with a masked region of interest (ROI) that appears to be localized around the oropharyngeal area, possibly involving the base of tongue or adjacent structures. The image contrast and anatomical landmarks suggest the presence of soft tissue structures typical for this region, including the tongue musculature, pharyngeal walls, and possibly lymph node regions.\n\nNo obvious gross abnormalities such as large necrotic masses or extensive nodal conglomerates are clearly visible in this single axial slice. However, the presence of a masked ROI suggests a targeted area of concern, likely corresponding to a tumor or involved lymph node.\n\nFrom a radiation oncology perspective, the key factors influencing survival probability in oropharyngeal squamous cell carcinoma include tumor stage, nodal involvement, HPV status, and treatment modality. HPV-positive tumors generally have a better prognosis. The absence of distant metastasis (M0) and the use of definitive radiation therapy are favorable factors.\n\nGiven the lack of detailed clinical data here, but assuming this is a typical HPV-positive oropharyngeal SCC case with localized disease and no distant spread, the survival probability would be relatively favorable.\n\nAnswer: Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: yes  \nReason: multidisciplinary input for treatment optimization  \n---",
        "Round 2-Turn 1-gap_identified-assistant": "- Multidisciplinary input for treatment optimization",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers. - Hierarchy: Medical Oncologist == Radiation Oncologist\n2. Surgical Oncologist (Recurrence/Secondary Cancers) - Your expertise is strictly limited to evaluating surgical options for recurrent or secondary malignancies in head and neck cancers. - Hierarchy: Surgical Oncologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "Step-by-step analysis:\n\n1. Patient is a 75.8-year-old female with good performance status (ECOG 0), which is favorable for treatment tolerance.\n2. Smoking history is significant (30 pack-years), but the patient is an ex-smoker, which may reduce ongoing risk.\n3. The primary tumor is located in the oropharynx, specifically the base of tongue, which is a common site for HPV-related squamous cell carcinoma.\n4. Tumor staging is T3N2cM0, corresponding to stage IVA disease, indicating a locally advanced tumor with bilateral lymph node involvement but no distant metastasis.\n5. Pathology confirms squamous cell carcinoma, HPV positive. HPV positivity is a strong favorable prognostic factor in oropharyngeal cancers, associated with better response to radiation and improved survival.\n6. Treatment was radiation therapy alone (60 Gy in 40 fractions) without chemotherapy. While combined chemoradiation is often standard for stage IVA, HPV positivity and good performance status may allow for radiation alone in selected cases.\n7. No local, regional, or distant recurrence noted at the time of imaging.\n8. Presence of a second cancer (2nd Ca: Y) is a negative prognostic factor, potentially impacting overall survival.\n9. Contrast-enhanced imaging was performed, but no specific abnormalities or residual disease are described in the provided data or image.\n\nConsidering the favorable HPV status, good performance status, and no evidence of disease progression, the patient likely has a reasonable survival probability despite the advanced stage and second cancer.\n\nAnswer: Alive",
        "Round 2-Turn 1-gap_recruited_assessment_review_assessment-medical oncologist": "Answer:Alive",
        "Round 2-Turn 1-gap_recruited_assessment-surgical oncologist (recurrence/secondary cancers)": "Step-by-step analysis as a surgical oncologist (recurrence/secondary cancers):\n\n1. Patient Characteristics:\n- Age 75.8 years, female, good performance status (ECOG 0).\n- Ex-smoker with significant smoking history (30 pack-years), which increases risk for secondary malignancies and complicates prognosis.\n\n2. Disease Characteristics:\n- Primary site: Oropharynx, specifically base of tongue.\n- Tumor stage T3, nodal stage N2c (bilateral or contralateral lymph node involvement), no distant metastasis (M0).\n- Stage IVA disease, which is locally advanced.\n- Pathology: Squamous cell carcinoma, HPV positive. HPV positivity generally confers better prognosis in oropharyngeal cancers.\n\n3. Treatment:\n- Treated with radiation therapy alone (60 Gy in 40 fractions), no chemotherapy.\n- No local, regional, or distant recurrence reported at this time.\n- Presence of a second cancer (2nd Ca: Y) is concerning for overall prognosis and potential for recurrence or complications.\n\n4. Imaging:\n- The CT scan provided does not show any obvious local recurrence or new lesions within the oropharynx or regional nodes.\n- No evidence of distant metastases on imaging.\n- No suspicious anatomical abnormalities or new masses visible in the masked ROI.\n\n5. Prognostic Considerations:\n- HPV positive oropharyngeal cancer generally has a favorable prognosis.\n- However, advanced nodal disease (N2c) and presence of a second primary malignancy negatively impact survival.\n- Radiation alone without chemotherapy may be suboptimal for T3N2c disease, potentially increasing risk of recurrence.\n- Patientâ€™s good performance status is favorable for potential salvage surgery if recurrence occurs.\n\n6. Surgical Oncology Perspective:\n- Close surveillance is warranted given the risk of recurrence.\n- If recurrence or secondary malignancy progression occurs, surgical salvage may be considered depending on location and extent.\n- The presence of a second cancer requires multidisciplinary management and may affect surgical options.\n\nFinal assessment: Given the HPV positivity, good performance status, and no current evidence of recurrence, the patient is likely to be alive at this point, but with guarded prognosis due to advanced nodal disease and second cancer.\n\nAnswer: Alive",
        "Round 2-Turn 1-gap_recruited_assessment_review_assessment-surgical oncologist (recurrence/secondary cancers)": "Answer:Alive",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate_review_assessment-medical oncologist": "Answer:Alive",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate_review_assessment-surgical oncologist (recurrence/secondary cancers)": "Answer:Alive",
        "Round 2-role-comment": "radiation oncologist:alive|medical oncologist:alive|surgical oncologist (recurrence/secondary cancers):alive",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "(radiation oncologist): Answer:Alive  \n(medical oncologist): Answer:Alive  \n(surgical oncologist (recurrence/secondary cancers)): Answer:Alive  \n\n('Answer: Alive',)"
    }
}